bg
S

Supernus Pharmaceuticals (SUPN)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more

  • USD32.71
  • USD33.80
  • USD32.55
  • USD40.28
  • -1.80%
  • 668M
  • 875.18k
  • 636.10k
  • 1.8B
  • 27.05
  • 22.40%
  • 15.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.